Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 4, 2013-05 ,pp. : 603-631

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccination with HPV16 Peptides of Patients with Advanced Cervical Carcinoma: Clinical Evaluation of a Phase I-II Trial

By van Driel W.J.   Ressing M.E.   Kenter G.G.   Brandt R.M.P.   Krul E.J.T.   van Rossum A.B.   Schuuring E.   Offringa R.   Bauknecht T.   Tamm-Hermelink A.   van Dam P.A.   Fleuren G.J.   Kast W.M.   Melief C.J.M.   Trimbos J.B.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 946-952

Elsevier

Access to resources Recommend Favorite

Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer

By                  

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 662-668

Spandidos Publications

Access to resources Recommend Favorite

Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer

By Yao Song  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 433-439

Springer Publishing Company

Access to resources Recommend Favorite

Information and communication in the context of a clinical trial

By Hietanen P.   Aro A.R.   Holli K.   Absetz P.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2096-2104

Elsevier

Access to resources Recommend Favorite